Joseph Limber

Joseph Limber

Directeur/Membre du Conseil chez XOMA ROYALTY CORPORATION

Fortune : 1 M $ au 31/05/2026

72 ans
Health Technology
Commercial Services
Health Services

Profil

Joseph M.
Limber
is currently Chief Executive Officer at Garda Therapeutics, Inc. and Independent Director at XOMA Royalty Corp.
Formerly, Mr. Limber was President & Chief Executive Officer at Monogram Biosciences, Inc. from 1998 to 2002; President & Chief Executive Officer at Deltagen, Inc. in 2003; President, Chief Executive Officer & Director at Genoptix, Inc. from 2017 to 2018; President & Chief Executive Officer at Gradalis, Inc. from 2013 to 2015; President, Chief Executive Officer & Director at Prometheus Laboratories, Inc. from 2004 to 2013; President, Chief Executive Officer & Director at Secura Bio, Inc.; Chairman at Molecular Insight Pharmaceuticals, Inc. in 2010; Executive Chairman at ImaginAb, Inc. from 2016 to 2017; Director at V.I.
Technologies, Inc.; Independent Non-Executive Director at CombiMatrix Corp.
in 2012; Director at Panacos Pharmaceuticals, Inc. from 2001 to 2009; Executive Vice President at SEQUUS Pharmaceuticals, Inc.; and President & Chief Operating Officer at Praecis Pharmaceuticals, Inc. from 1996 to 1998.
Education includes undergraduate studies at Duquesne University of The Holy Spirit.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
21/05/2026 12 820 ( 0,1% ) 534 722 $ 31/05/2026
21/05/2026 20 000 ( 1,14% ) 506 800 $ 31/05/2026
21/05/2026 10 000 ( 1,02% ) 254 550 $ 31/05/2026

Postes actifs de Joseph Limber

SociétésPosteDébut
XOMA ROYALTY CORPORATION Directeur/Membre du Conseil 13/12/2012

Anciens postes connus de Joseph Limber

SociétésPosteFin
Directeur Général 01/12/2018
Président 01/11/2017
Directeur Général 01/04/2015
Directeur Général 01/04/2013
COMBIMATRIX CORP Directeur/Membre du Conseil 09/10/2012
Voir l'expérience en détail de Joseph Limber

Formation de Joseph Limber

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

68

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Services

Health Technology

Health Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Joseph Limber
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT